Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Cash from Investing Activities (2018 - 2025)

10x Genomics (TXG) has disclosed Cash from Investing Activities for 8 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 96.5% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.4 million through Dec 2025, up 58.82% year-over-year, with the annual reading at -$13.4 million for FY2025, 58.82% up from the prior year.
  • Cash from Investing Activities hit -$1.8 million in Q4 2025 for 10x Genomics, up from -$8.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $120.0 million in Q1 2023 to a low of -$257.6 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged -$18.5 million across 5 years, with a median of -$6.6 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: crashed 1444.05% in 2021 and later surged 367.75% in 2024.
  • Year by year, Cash from Investing Activities stood at -$27.6 million in 2021, then dropped by 20.11% to -$33.2 million in 2022, then soared by 139.49% to $13.1 million in 2023, then tumbled by 493.89% to -$51.6 million in 2024, then surged by 96.5% to -$1.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for TXG at -$1.8 million in Q4 2025, -$8.8 million in Q3 2025, and -$939000.0 in Q2 2025.